切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2021, Vol. 10 ›› Issue (06) : 618 -621. doi: 10.3877/cma.j.issn.2095-3232.2021.06.018

临床研究

原发性肝平滑肌肉瘤诊断与治疗
武洋1, 苗润晨1, 张兴1, 张月浪2, 马小华1, 刘昌1,()   
  1. 1. 710061 西安交通大学第一附属医院肝胆外科
    2. 710061 西安交通大学第一附属医院影像科
  • 收稿日期:2021-08-24 出版日期:2021-09-23
  • 通信作者: 刘昌

Diagnosis and treatments of primary hepatic leiomyosarcoma

Yang Wu1, Runchen Miao1, Xing Zhang1, Yuelang Zhang2, Xiaohua Ma1, Chang Liu1,()   

  1. 1. Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
    2. Department of Imaging, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
  • Received:2021-08-24 Published:2021-09-23
  • Corresponding author: Chang Liu
引用本文:

武洋, 苗润晨, 张兴, 张月浪, 马小华, 刘昌. 原发性肝平滑肌肉瘤诊断与治疗[J]. 中华肝脏外科手术学电子杂志, 2021, 10(06): 618-621.

Yang Wu, Runchen Miao, Xing Zhang, Yuelang Zhang, Xiaohua Ma, Chang Liu. Diagnosis and treatments of primary hepatic leiomyosarcoma[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2021, 10(06): 618-621.

目的

探讨原发性肝平滑肌肉瘤的诊治方法。

方法

回顾性分析2017年10月在西安交通大学第一附属医院诊治的1例原发性肝平滑肌肉瘤患者临床资料。患者女,49岁,因"超声检查发现肝占位性病变"入院。超声检查示肝脏尾叶低回声区。腹部CT检查示肝右叶及尾状叶可见多发结节状及团块状低密度影。肝穿刺活检、免疫组化染色确诊原发性肝平滑肌肉瘤。治疗方案为TACE联合化疗。

结果

患者于2017年12月14日行TACE治疗,术后给予6个疗程的辅助化疗(吉西他滨+多西他赛)。2019年4月16日复查发现病变较前略扩大,化疗方案改为吉西他滨+白蛋白结合型紫杉醇,化疗3个周期。2020年5月20日复查提示病灶明显增大,再次行TACE治疗,术后患者恢复良好。截至2020年7月1日,患者生存质量良好,随访未见肿瘤复发。检索2000~2020年Pubmed共收录15例成年原发性肝平滑肌肉瘤患者,其中男6例,女9例;年龄25~77岁,中位年龄54岁。初发症状多表现为腹痛伴不适,肿瘤多发于右叶。实验室检查和影像学缺乏特异性表现。病理学检查示梭形组织细胞聚集呈束状排列;免疫组化染色示组织细胞SMA、desmin、vimentin阳性,S-100、细胞角蛋白阴性。手术切除9例,化疗2例,其中1例手术后联合化疗,肝移植术1例,TACE 2例,保守治疗2例。随访3~82个月,失访2例,死亡6例,存活7例。

结论

原发性肝平滑肌肉瘤是一种罕见疾病,病理学检查是确诊的唯一有效方式,手术切除可获得较好的疗效。

Objective

To investigate the diagnosis and treatments of primary hepatic leiomyosarcoma (PHL).

Methods

Clinical data of 1 patient with PHL who was diagnosed and treated in the First Affiliated Hospital of Xi'an Jiaotong University in October 2017 were analyzed retrospectively. The female patient, aged 49 years, was admitted to our hospital due to "space-occupying lesions of the liver detected by ultrasound examination". A hypoechoic region in the caudate lobe of liver was found by ultrasound examination. Multiple nodule-like and lumpy low-density shadows in the right lobe and caudate lobe were observed by abdominal CT scan. The diagnosis of PHL was confirmed by liver biopsy and immunohistochemical staining. TACE combined with chemotherapy was adopted.

Results

The patient received TACE on December 14, 2017, and was given with 6 cycles of adjuvant chemotherapy (gemcitabine+docetaxel) after TACE. The lesion was found slightly enlarged in the reexamination on April 16, 2019 and the chemotherapy regimen was modified to gemcitabine + albumin-bound paclitaxel for 3 cycles. On May 20, 2020, the reexamination found that the lesion was obviously enlarged. After the secondary TACE, the patient recovered well. As of July 1, 2020, the patient had lived a high quality of life, and no tumor recurrence was found during postoperative follow-up. Clinical data of 15 adult patients with PHL were retrieved from PubMed database between 2000 and 2020. 6 cases were male and 9 female, aged from 25 to 77 years, with a median age of 54 years. The primary symptoms were mainly abdominal pain and discomfort, and the tumors were mainly located in the right lobe. No specific manifestations was observed in laboratory and imaging examination. Pathological examination showed that spindle-shaped tissue cells were arranged in bundles. Immunohistochemical staining found positive results for SMA, desmin and vimentin, whereas negative results for S-100 and cytokeratin in the tissue cells. Surgical resection was performed in 9 cases, chemotherapy in 2, including 1 of surgical resection combined with chemotherapy, liver transplantation in 1, TACE in 2 and conservative treatments in 2, respectively. During 3-82 month follow-up, 2 cases were lost to follow-up, 6 cases died and 7 survived.

Conclusions

PHL is a rare disease. Pathological examination is the only effective approach to confirm the diagnosis. Surgical resection can achieve relatively better clinical efficacy.

图1 一例原发性肝平滑肌肉瘤患者肝脏增强CT图注:a为动脉期,b为静脉期,c为门静脉期;示肝右叶及尾叶见6.7 cm×6.8 cm的实性软组织肿块影,呈快进快出征象(箭头所示)
[1]
Tsuji M, Takenaka R, Kashihara T, et al. Primary hepatic leiomyosarcoma in a patient with hepatitis C virus-related liver cirrhosis[J]. Pathol Int, 2010, 50(1):41-47.
[2]
Fujita H, Kiriyama M, Kawamura T, et al. Primary hepatic leiomyosarcoma in a woman after renal transplantation: report ofa case[J]. Surg Today, 2002, 32(5):446-449.
[3]
Iordanidis F, Hytiroglou P, Drevelegas A, et al. A 25-year-old man with a large hepatic tumor and multiple nodular lesions[J]. Semin Liver Dis, 2002, 22(1):97-102.
[4]
Lee HJ, Lee JL, Choi WH. A case of primary myxoid leiomyosarcoma of the liver[J]. Korean J Intern Med, 2002, 17(4):278-282.
[5]
Tsiatis AC, Atkinson JB, Wright JK, et al. Primary hepatic myxoid leiomyosarcoma: a case report and review of the literature[J]. Ultrastruct Pathol, 2008, 32(1):25-28.
[6]
Liang X, Shi XM, Xie JP, et al. Liver transplantation for primary hepatic leiomyosarcoma: a case report and review of the literatures[J]. Med Oncol, 2010, 27(4):1269-1272.
[7]
Shivathirthan N, Kita J, Iso Y, et al. Primary hepatic leiomyosarcoma: case report and literature review[J]. World J Gastrointest Oncol, 2011, 3(10):148-152.
[8]
Chelimilla H, Badipatla K, Ihimoyan A, et al. A rare occurrence of primary hepatic leiomyosarcoma associated with epstein barr virus infection in an AIDS patient[J]. Case Rep Gastrointest Med, 2013: 691862.
[9]
Lv WF, Han JK, Cheng DL, et al. Imaging features of primary hepatic leiomyosarcoma: a case report and review of literature[J]. Oncol Lett, 2015, 9(5):2256-2260.
[10]
Giakoustidis D, Giakoustidis A, Goulopoulos T, et al. Primary gigantic leiomyosarcoma of the liver treated with portal vein embolization and liver resection[J]. Ann Hepatobiliary Pancreat Surg, 2017, 21(4):228-231.
[11]
Feretis T, Kostakis ID, Damaskos C, et al. Primary hepatic leiomyosarcoma: a case report and review of the literature[J]. Acta Medica, 2018, 61(4):153-157.
[12]
Liu W, Liang W. Primary hepatic leiomyosarcoma presenting asa thick-walled cystic mass resembling a liver abscess: a case report[J]. Medicine, 2018, 97(51):e13861.
[13]
Mitra S, Rathi S, Debi U, et al. Primary hepatic leiomyosarcoma: histopathologist's perspective of a rare case[J]. J Clin Exp Hepatol, 2018, 8(3):321326.
[14]
Zhu KL, Cai XJ. Primary hepatic leiomyosarcoma successfully treated by transcatheter arterial chemoembolization: a case report[J]. World J Clin Cases, 2019, 7(4):525-531.
[15]
Vella S, Cortis K, Pisani D, et al. Case of primary hepatic leiomyosarcoma successfully treated with laparoscopic right hepatectomy[J]. BMJ Case Rep, 2020, 13(2):e233567.
[16]
Weitz J, Klimstra DS, Cymes K, et al. Management of primary liver sarcomas[J]. Cancer, 2007, 109(7):1391-13960.
[17]
Yamaguchi J, Azuma T, Fujioka H, et al. Leiomyosarcoma occurring in the ligamentum teres of the liver: a case report and a review of seven reported cases[J]. Hepatogastroenterology, 1996, 43(10):1051-1056.
[18]
Pinson CW, Lopez RR, Ivancev K, et al. Resection of primary hepatic malignant fibrous histiocytoma, fibrosarcoma, and leiomyosarcoma[J]. South Med J, 1994, 87(3):384-391.
[19]
Iida T, Maeda T, Amari Y, et al. Primary hepatic leiomyosarcoma ina patient with autosomal dominant polycystic kidney disease[J]. CEN Case Rep, 2017, 6(1):74-78.
[20]
马学真. 软组织肉瘤的诊断和治疗[C]//山东抗癌协会肿瘤化疗分会. 山东省第七届肿瘤化疗会议暨首届"CSCO-山东"肿瘤论坛论文集, 山东潍坊, 2008.
[21]
Husted TL, Neff G, Thomas MJ, et al. Liver transplantation for primary or metastatic sarcoma to the liver[J]. Am J Transplant, 2006, 6(2):392-397.
[1] 杨水华, 何桂丹, 覃桂灿, 梁蒙凤, 罗艳合, 李雪芹, 唐娟松. 胎儿孤立性完全型肺静脉异位引流的超声心动图特征及高分辨率血流联合时间-空间相关成像的应用[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1061-1067.
[2] 韩丹, 王婷, 肖欢, 朱丽容, 陈镜宇, 唐毅. 超声造影与增强CT对儿童肝脏良恶性病变诊断价值的对比分析[J]. 中华医学超声杂志(电子版), 2023, 20(09): 939-944.
[3] 江泽莹, 王安婷, 王姣丽, 陈慈, 周秋玲, 黄燕娟, 周芳, 薛琰, 周剑烽, 谭文勇, 杜美芳. 多种植物油组分预防肿瘤放化疗相关毒性反应的效果分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 523-527.
[4] 朴广昊, 李屹洲, 刘瑞, 赵建民, 王凌峰. 皮肤撕脱伤撕脱皮瓣活力早期评估与修复的研究进展[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 528-532.
[5] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[6] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[7] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[8] 蓝冰, 王怀明, 王辉, 马波. 局部晚期结肠癌膀胱浸润的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 505-511.
[9] 杨红杰, 张智春, 孙轶. 直肠癌淋巴结转移诊断研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 512-518.
[10] 袁媛, 赵良平, 刘智慧, 张丽萍, 谭丽梅, 閤梦琴. 子宫内膜癌组织中miR-25-3p、PTEN的表达及与病理参数的关系[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1016-1020.
[11] 陆志峰, 周佳佳, 梁舒. 虚拟现实技术在治疗弱视中的临床应用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 891-895.
[12] 李田, 徐洪, 刘和亮. 尘肺病的相关研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 900-905.
[13] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
[14] 周婷, 孙培培, 张二明, 安欣华, 向平超. 北京市石景山区40岁及以上居民慢性阻塞性肺疾病诊断现状调查[J]. 中华临床医师杂志(电子版), 2023, 17(07): 790-797.
[15] 符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.
阅读次数
全文


摘要